WebA new clinical trial aims to evaluate a latest-generation drug-eluting stent in patients with stable ischaemic heart disease who might require a shorter dual antiplatelet regimen. WebAug 20, 2014 · KW, Storey R F, Harrington RA, Wallentin L. Bleeding complications with the P2Y12 receptor . antagonists clopidogrel and ticagrelor in the . PLA Telet inhibition and …
Researcher Profile: Lars Wallentin - Uppsala University
WebFeb 28, 2024 · 5 Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey … WebIn 1991, Lars Wallentin became the first Professor of Cardiology at Uppsala University, where he founded and was head of the coronary care unit from 1991 to 1999. In 1992, he … device manager windows download
Startseite Kunz Wallentin Rechtsanwälte
WebSep 1, 2013 · The recent development and approval of novel oral anticoagulants represents a significant success in the intelligent design of target-specific therapeutics. However, … WebOct 18, 2013 · Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, … WebAug 29, 2024 · Myocardial infarction (MI) is the most serious complication of coronary artery disease. In the last decades the progress in treatment of MI has led to a significant improvement of prognosis. Nonetheless, despite a generally high prevalence of guideline-recommended therapies, especially percutaneous revascularization, the mortality rates … device manager yellow bang